{"id":44470,"date":"2022-05-30T17:01:36","date_gmt":"2022-05-30T15:01:36","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/acute-social-anxiety-disorder-market-insights-epidemiology-and-market-forecasts-2019-2021-2022-2032-researchandmarkets-com\/"},"modified":"2022-05-30T17:01:36","modified_gmt":"2022-05-30T15:01:36","slug":"acute-social-anxiety-disorder-market-insights-epidemiology-and-market-forecasts-2019-2021-2022-2032-researchandmarkets-com","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/acute-social-anxiety-disorder-market-insights-epidemiology-and-market-forecasts-2019-2021-2022-2032-researchandmarkets-com\/","title":{"rendered":"Acute Social Anxiety Disorder Market Insights, Epidemiology and Market Forecasts, 2019-2021 &amp; 2022-2032 &#8211; ResearchAndMarkets.com"},"content":{"rendered":"<div>\n<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/5524646\/acute-social-anxiety-disorder-market-insight?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=prr6nc&amp;utm_campaign=1706797+-+Acute+Social+Anxiety+Disorder+Market+Insights%2C+Epidemiology+and+Market+Forecasts%2C+2019-2021+%26+2022-2032&amp;utm_exec=chdo54prd\" rel=\"nofollow noopener\" shape=\"rect\">&#8220;Acute Social Anxiety Disorder &#8211; Market Insight, Epidemiology and Market Forecast -2032&#8221;<\/a> report has been added to <strong>ResearchAndMarkets.com&#8217;s<\/strong> offering.\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20220530005300\/en\/1470459\/4\/logo.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20220530005300\/en\/1470459\/21\/logo.jpg\"><\/a><\/p>\n<p>\nThis &#8220;Acute Social Anxiety Disorder- Market Insights, Epidemiology, and Market Forecast-2032&#8221; report delivers an in-depth understanding of the Acute Social Anxiety Disorder, historical and forecasted epidemiology as well as the Acute Social Anxiety Disorder market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.\n<\/p>\n<p>\n<strong>Acute Social Anxiety Disorder Epidemiology<\/strong>\n<\/p>\n<p>\nThe Acute Social Anxiety Disorder epidemiology division provide insights about historical and current Acute Social Anxiety Disorder patient pool and forecasted trend for every seven major countries. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. This part of The report also provides the diagnosed patient pool and their trends along with assumptions undertaken.\n<\/p>\n<p>\n<strong>Key Findings<\/strong>\n<\/p>\n<p>\nThe disease epidemiology covered in the report provides historical as well as forecasted Acute Social Anxiety Disorder epidemiology scenario in the 7MM covering the United States, EU5 countries (Germany, Spain, Italy, France, and the United Kingdom), and Japan from 2019 to 2032.\n<\/p>\n<p>\n<strong>Acute Social Anxiety Disorder Drug Chapters<\/strong>\n<\/p>\n<p>\nDrug chapter segment of the Acute Social Anxiety Disorder report encloses the detailed analysis of Acute Social Anxiety Disorder marketed drugs and late stage (Phase-III and Phase-II) pipeline drugs. It also helps to understand the Acute Social Anxiety Disorder clinical trial details, expressive pharmacological action, agreements and collaborations, approval and patent details, advantages and disadvantages of each included drug and the latest news and press releases.\n<\/p>\n<p>\n<strong>Marketed Drugs<\/strong>\n<\/p>\n<p>\nThe report provides the details of the marketed product available for Acute Social Anxiety Disorder treatment.\n<\/p>\n<p>\n<strong>Acute Social Anxiety Disorder Emerging Drugs<\/strong>\n<\/p>\n<p>\nThe report provides the details of the emerging therapies under the late and mid-stage of development for Acute Social Anxiety Disorder treatment.\n<\/p>\n<p>\n<strong>Acute Social Anxiety Disorder Market Outlook<\/strong>\n<\/p>\n<p>\nThe Acute Social Anxiety Disorder market outlook of the report helps to build the detailed comprehension of the historic, current, and forecasted Acute Social Anxiety Disorder market trends by analyzing the impact of current therapies on the market, unmet needs, drivers and barriers and demand of better technology.\n<\/p>\n<p>\n<strong>Acute Social Anxiety Disorder Drugs Uptake<\/strong>\n<\/p>\n<p>\nThis section focusses on the rate of uptake of the potential drugs recently launched in the Acute Social Anxiety Disorder market or expected to get launched in the market during the study period 2019-2032. The analysis covers Acute Social Anxiety Disorder market uptake by drugs; patient uptake by therapies; and sales of each drug.\n<\/p>\n<p>\nThis helps in understanding the drugs with the most rapid uptake, reasons behind the maximal use of new drugs and allow the comparison of the drugs on the basis of market share and size which again will be useful in investigating factors important in market uptake and in making financial and regulatory decisions.\n<\/p>\n<p>\n<strong>Acute Social Anxiety Disorder Pipeline Development Activities<\/strong>\n<\/p>\n<p>\nThe report provides insights into different therapeutic candidates in Phase II, and Phase III stage. It also analyses Acute Social Anxiety Disorder key players involved in developing targeted therapeutics.\n<\/p>\n<p>\n<strong>Pipeline Development Activities<\/strong>\n<\/p>\n<p>\nThe report covers the detailed information of collaborations, acquisition and merger, licensing, patent details and other information for Acute Social Anxiety Disorder emerging therapies.\n<\/p>\n<p>\n<strong>Reimbursement Scenario in Acute Social Anxiety Disorder<\/strong>\n<\/p>\n<p>\nApproaching reimbursement proactively can have a positive impact both during the late stages of product development and well after product launch. In a report, we take reimbursement into consideration to identify economically attractive indications and market opportunities. When working with finite resources, the ability to select the markets with the fewest reimbursement barriers can be a critical business and price strategy.\n<\/p>\n<p>\n<strong>KOL-Views<\/strong>\n<\/p>\n<p>\nTo keep up with current market trends, we take KOLs and SME&#8217;s opinion working in Acute Social Anxiety Disorder domain through primary research to fill the data gaps and validate our secondary research. Their opinion helps to understand and validate current and emerging therapies treatment patterns or Acute Social Anxiety Disorder market trend. This will support the clients in potential upcoming novel treatment by identifying the overall scenario of the market and the unmet needs.\n<\/p>\n<p>\n<strong>Competitive Intelligence Analysis<\/strong>\n<\/p>\n<p>\nThe publisher performs Competitive and Market Intelligence analysis of the Acute Social Anxiety Disorder Market by using various Competitive Intelligence tools that include &#8211; SWOT analysis, PESTLE analysis, Porter&#8217;s five forces, BCG Matrix, Market entry strategies etc. The inclusion of the analysis entirely depends upon the data availability.\n<\/p>\n<p>\n<strong>Key Topics Covered:<\/strong>\n<\/p>\n<p>\n<strong>1. Key Insights<\/strong>\n<\/p>\n<p>\n<strong>2. Executive Summary of Acute Social Anxiety Disorder<\/strong>\n<\/p>\n<p>\n<strong>3. Competitive Intelligence Analysis for Acute Social Anxiety Disorder<\/strong>\n<\/p>\n<p>\n<strong>4. Acute Social Anxiety Disorder: Market Overview at a Glance<\/strong>\n<\/p>\n<p>\n4.1. Acute Social Anxiety Disorder Total Market Share (%) Distribution in 2019\n<\/p>\n<p>\n4.2. Acute Social Anxiety Disorder Total Market Share (%) Distribution in 2032\n<\/p>\n<p>\n<strong>5. Acute Social Anxiety Disorder: Disease Background and Overview<\/strong>\n<\/p>\n<p>\n5.1. Introduction\n<\/p>\n<p>\n5.2. Sign and Symptoms\n<\/p>\n<p>\n5.3. Pathophysiology\n<\/p>\n<p>\n5.4. Risk Factors\n<\/p>\n<p>\n5.5. Diagnosis\n<\/p>\n<p>\n<strong>6. Patient Journey<\/strong>\n<\/p>\n<p>\n<strong>7. Acute Social Anxiety Disorder Epidemiology and Patient Population<\/strong>\n<\/p>\n<p>\n7.1. Epidemiology Key Findings\n<\/p>\n<p>\n7.2. Assumptions and Rationale: 7MM\n<\/p>\n<p>\n7.3. Epidemiology Scenario: 7MM\n<\/p>\n<p>\n7.3.1. Acute Social Anxiety Disorder Epidemiology Scenario in the 7MM (2019-2032)\n<\/p>\n<p>\n7.4. United States Epidemiology\n<\/p>\n<p>\n7.5. EU-5 Country-wise Epidemiology\n<\/p>\n<p>\n7.5.1. Germany Epidemiology\n<\/p>\n<p>\n7.5.2. France Epidemiology\n<\/p>\n<p>\n7.5.3. Italy Epidemiology\n<\/p>\n<p>\n7.5.4. Spain Epidemiology\n<\/p>\n<p>\n7.5.5. United Kingdom Epidemiology\n<\/p>\n<p>\n7.5.6. Japan Epidemiology\n<\/p>\n<p>\n<strong>8. Treatment Algorithm, Current Treatment, and Medical Practices<\/strong>\n<\/p>\n<p>\n8.1. Acute Social Anxiety Disorder Treatment and Management\n<\/p>\n<p>\n8.2. Acute Social Anxiety Disorder Treatment Algorithm\n<\/p>\n<p>\n<strong>9. Unmet Needs<\/strong>\n<\/p>\n<p>\n<strong>10. Key Endpoints of Acute Social Anxiety Disorder Treatment<\/strong>\n<\/p>\n<p>\n<strong>11. Marketed Products<\/strong>\n<\/p>\n<p>\n<strong>12. Emerging Therapies<\/strong>\n<\/p>\n<p>\n<strong>13. Acute Social Anxiety Disorder: Seven Major Market Analysis<\/strong>\n<\/p>\n<p>\n13.1. Key Findings\n<\/p>\n<p>\n13.2. Acute Social Anxiety Disorder Market Size in 7MM\n<\/p>\n<p>\n13.3. Acute Social Anxiety Disorder Market Size by Therapies in the 7MM\n<\/p>\n<p>\n<strong>14. Attribute analysis<\/strong>\n<\/p>\n<p>\n<strong>15. 7MM: Market Outlook<\/strong>\n<\/p>\n<p>\n15.1. United States: Market Size\n<\/p>\n<p>\n15.1.1. Acute Social Anxiety Disorder Total Market Size in the United States\n<\/p>\n<p>\n15.1.2. Acute Social Anxiety Disorder Market Size by Therapies in the United States\n<\/p>\n<p>\n15.2. EU-5 countries: Market Size and Outlook\n<\/p>\n<p>\n15.3. Germany Market Size\n<\/p>\n<p>\n15.4. France Market Size\n<\/p>\n<p>\n15.5. Italy Market Size\n<\/p>\n<p>\n15.6. Spain Market Size\n<\/p>\n<p>\n15.7. United Kingdom Market Size\n<\/p>\n<p>\n15.8. Japan Market Outlook\n<\/p>\n<p>\n15.8.1. Japan Market Size\n<\/p>\n<p>\n<strong>16. Access and Reimbursement Overview of Acute Social Anxiety Disorder<\/strong>\n<\/p>\n<p>\n<strong>17. KOL Views<\/strong>\n<\/p>\n<p>\n<strong>18. Market Drivers<\/strong>\n<\/p>\n<p>\n<strong>19. Market Barriers<\/strong>\n<\/p>\n<p>\n<strong>20. Appendix<\/strong>\n<\/p>\n<p>\nFor more information about this report visit <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/5524646\/acute-social-anxiety-disorder-market-insight?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=prr6nc&amp;utm_campaign=1706797+-+Acute+Social+Anxiety+Disorder+Market+Insights%2C+Epidemiology+and+Market+Forecasts%2C+2019-2021+%26+2022-2032&amp;utm_exec=chdo54prd\" rel=\"nofollow noopener\" shape=\"rect\">https:\/\/www.researchandmarkets.com\/r\/3r3yv0<\/a>\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\nResearchAndMarkets.com<br \/>\n<br \/>Laura Wood, Senior Press Manager<br \/>\n<br \/><a target=\"_blank\" href=\"&#x6d;&#x61;&#105;lt&#x6f;&#x3a;&#112;&#114;e&#x73;&#x73;&#64;&#114;e&#x73;&#x65;&#x61;&#114;ch&#x61;&#x6e;&#100;&#109;a&#x72;&#x6b;&#101;&#116;s&#x2e;&#x63;&#111;&#109;\" rel=\"nofollow noopener\" shape=\"rect\">&#x70;r&#x65;&#115;s&#x40;&#114;&#x65;&#115;e&#x61;&#114;&#x63;&#104;a&#x6e;&#100;&#x6d;&#x61;r&#x6b;&#101;t&#x73;&#46;&#x63;&#111;m<\/a><br \/>For E.S.T Office Hours Call 1-917-300-0470<br \/>\n<br \/>For U.S.\/CAN Toll Free Call 1-800-526-8630<br \/>\n<br \/>For GMT Office Hours Call +353-1-416-8900\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Acute Social Anxiety Disorder &#8211; Market Insight, Epidemiology and Market Forecast -2032&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. This &#8220;Acute Social Anxiety Disorder- Market Insights, Epidemiology, and Market Forecast-2032&#8221; report delivers an in-depth understanding of the Acute Social Anxiety Disorder, historical and forecasted epidemiology as well as the Acute Social Anxiety Disorder &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/acute-social-anxiety-disorder-market-insights-epidemiology-and-market-forecasts-2019-2021-2022-2032-researchandmarkets-com\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-44470","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Acute Social Anxiety Disorder Market Insights, Epidemiology and Market Forecasts, 2019-2021 &amp; 2022-2032 - ResearchAndMarkets.com - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/acute-social-anxiety-disorder-market-insights-epidemiology-and-market-forecasts-2019-2021-2022-2032-researchandmarkets-com\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Acute Social Anxiety Disorder Market Insights, Epidemiology and Market Forecasts, 2019-2021 &amp; 2022-2032 - ResearchAndMarkets.com - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Acute Social Anxiety Disorder &#8211; Market Insight, Epidemiology and Market Forecast -2032&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. This &#8220;Acute Social Anxiety Disorder- Market Insights, Epidemiology, and Market Forecast-2032&#8221; report delivers an in-depth understanding of the Acute Social Anxiety Disorder, historical and forecasted epidemiology as well as the Acute Social Anxiety Disorder ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/acute-social-anxiety-disorder-market-insights-epidemiology-and-market-forecasts-2019-2021-2022-2032-researchandmarkets-com\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-05-30T15:01:36+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220530005300\/en\/1470459\/21\/logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/acute-social-anxiety-disorder-market-insights-epidemiology-and-market-forecasts-2019-2021-2022-2032-researchandmarkets-com\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/acute-social-anxiety-disorder-market-insights-epidemiology-and-market-forecasts-2019-2021-2022-2032-researchandmarkets-com\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Acute Social Anxiety Disorder Market Insights, Epidemiology and Market Forecasts, 2019-2021 &amp; 2022-2032 &#8211; ResearchAndMarkets.com\",\"datePublished\":\"2022-05-30T15:01:36+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/acute-social-anxiety-disorder-market-insights-epidemiology-and-market-forecasts-2019-2021-2022-2032-researchandmarkets-com\\\/\"},\"wordCount\":1053,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/acute-social-anxiety-disorder-market-insights-epidemiology-and-market-forecasts-2019-2021-2022-2032-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220530005300\\\/en\\\/1470459\\\/21\\\/logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/acute-social-anxiety-disorder-market-insights-epidemiology-and-market-forecasts-2019-2021-2022-2032-researchandmarkets-com\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/acute-social-anxiety-disorder-market-insights-epidemiology-and-market-forecasts-2019-2021-2022-2032-researchandmarkets-com\\\/\",\"name\":\"Acute Social Anxiety Disorder Market Insights, Epidemiology and Market Forecasts, 2019-2021 &amp; 2022-2032 - ResearchAndMarkets.com - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/acute-social-anxiety-disorder-market-insights-epidemiology-and-market-forecasts-2019-2021-2022-2032-researchandmarkets-com\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/acute-social-anxiety-disorder-market-insights-epidemiology-and-market-forecasts-2019-2021-2022-2032-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220530005300\\\/en\\\/1470459\\\/21\\\/logo.jpg\",\"datePublished\":\"2022-05-30T15:01:36+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/acute-social-anxiety-disorder-market-insights-epidemiology-and-market-forecasts-2019-2021-2022-2032-researchandmarkets-com\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/acute-social-anxiety-disorder-market-insights-epidemiology-and-market-forecasts-2019-2021-2022-2032-researchandmarkets-com\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/acute-social-anxiety-disorder-market-insights-epidemiology-and-market-forecasts-2019-2021-2022-2032-researchandmarkets-com\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220530005300\\\/en\\\/1470459\\\/21\\\/logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220530005300\\\/en\\\/1470459\\\/21\\\/logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/acute-social-anxiety-disorder-market-insights-epidemiology-and-market-forecasts-2019-2021-2022-2032-researchandmarkets-com\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Acute Social Anxiety Disorder Market Insights, Epidemiology and Market Forecasts, 2019-2021 &amp; 2022-2032 &#8211; ResearchAndMarkets.com\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Acute Social Anxiety Disorder Market Insights, Epidemiology and Market Forecasts, 2019-2021 &amp; 2022-2032 - ResearchAndMarkets.com - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/acute-social-anxiety-disorder-market-insights-epidemiology-and-market-forecasts-2019-2021-2022-2032-researchandmarkets-com\/","og_locale":"en_US","og_type":"article","og_title":"Acute Social Anxiety Disorder Market Insights, Epidemiology and Market Forecasts, 2019-2021 &amp; 2022-2032 - ResearchAndMarkets.com - Pharma Trend","og_description":"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Acute Social Anxiety Disorder &#8211; Market Insight, Epidemiology and Market Forecast -2032&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. This &#8220;Acute Social Anxiety Disorder- Market Insights, Epidemiology, and Market Forecast-2032&#8221; report delivers an in-depth understanding of the Acute Social Anxiety Disorder, historical and forecasted epidemiology as well as the Acute Social Anxiety Disorder ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/acute-social-anxiety-disorder-market-insights-epidemiology-and-market-forecasts-2019-2021-2022-2032-researchandmarkets-com\/","og_site_name":"Pharma Trend","article_published_time":"2022-05-30T15:01:36+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220530005300\/en\/1470459\/21\/logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/acute-social-anxiety-disorder-market-insights-epidemiology-and-market-forecasts-2019-2021-2022-2032-researchandmarkets-com\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/acute-social-anxiety-disorder-market-insights-epidemiology-and-market-forecasts-2019-2021-2022-2032-researchandmarkets-com\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Acute Social Anxiety Disorder Market Insights, Epidemiology and Market Forecasts, 2019-2021 &amp; 2022-2032 &#8211; ResearchAndMarkets.com","datePublished":"2022-05-30T15:01:36+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/acute-social-anxiety-disorder-market-insights-epidemiology-and-market-forecasts-2019-2021-2022-2032-researchandmarkets-com\/"},"wordCount":1053,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/acute-social-anxiety-disorder-market-insights-epidemiology-and-market-forecasts-2019-2021-2022-2032-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220530005300\/en\/1470459\/21\/logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/acute-social-anxiety-disorder-market-insights-epidemiology-and-market-forecasts-2019-2021-2022-2032-researchandmarkets-com\/","url":"https:\/\/pharma-trend.com\/en\/acute-social-anxiety-disorder-market-insights-epidemiology-and-market-forecasts-2019-2021-2022-2032-researchandmarkets-com\/","name":"Acute Social Anxiety Disorder Market Insights, Epidemiology and Market Forecasts, 2019-2021 &amp; 2022-2032 - ResearchAndMarkets.com - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/acute-social-anxiety-disorder-market-insights-epidemiology-and-market-forecasts-2019-2021-2022-2032-researchandmarkets-com\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/acute-social-anxiety-disorder-market-insights-epidemiology-and-market-forecasts-2019-2021-2022-2032-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220530005300\/en\/1470459\/21\/logo.jpg","datePublished":"2022-05-30T15:01:36+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/acute-social-anxiety-disorder-market-insights-epidemiology-and-market-forecasts-2019-2021-2022-2032-researchandmarkets-com\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/acute-social-anxiety-disorder-market-insights-epidemiology-and-market-forecasts-2019-2021-2022-2032-researchandmarkets-com\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/acute-social-anxiety-disorder-market-insights-epidemiology-and-market-forecasts-2019-2021-2022-2032-researchandmarkets-com\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220530005300\/en\/1470459\/21\/logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220530005300\/en\/1470459\/21\/logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/acute-social-anxiety-disorder-market-insights-epidemiology-and-market-forecasts-2019-2021-2022-2032-researchandmarkets-com\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Acute Social Anxiety Disorder Market Insights, Epidemiology and Market Forecasts, 2019-2021 &amp; 2022-2032 &#8211; ResearchAndMarkets.com"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/44470","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=44470"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/44470\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=44470"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=44470"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=44470"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}